Article
Growth hormone receptor (GHR) exon 3 polymorphism status detection by dual-enzyme-linked immunosorbent assay (ELISA).
The Journal of clinical endocrinology and metabolism - 1 Jan 2013
Wan JunXiang, Atzmon Gil, Hwang David, Barzlai Nir, Kratzsch Jurgen, Cohen Pinchas
Abstract excerpt
CONTEXT: GH receptor (GHR) exon 3-deleted/full-length (d3/fl) polymorphism has been proposed to affect the responsiveness to GH therapy. Conventional multiplex PCR genotyping method for this polymorphism detection requires DNA samples, which may be difficult to obtain due to ethical and procedural issues and may limit further studies into the role of this polymorphism in health and disease. OBJECTIVE: The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
